Body dysmorphic disorder

A. Allen, Eric Hollander

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The understanding of BDD and its treatment has expanded significantly in the past decade as controlled research has followed the leads from case reports and clinical experience. BDD is recognized as a severe, disabling disorder that is more common that had been assumed. Although BDD is still difficult to treat, success has been demonstrated for SRIs and CBT. Much remains to be discovered. To date, little is known about the causes and pathophysiology of BDD. Research that would illuminate these also would increase understanding of its relationship to other disorders, such as OCD, depression, and social phobia, and open up possibilities for prevention and new approaches to treatment. Investigations in brain imaging and genetics are underway. Research in pharmacotherapy and CBT, individually and combined, is needed to refine, extend, and optimize treatment.

Original languageEnglish (US)
Pages (from-to)617-628
Number of pages12
JournalPsychiatric Clinics of North America
Volume23
Issue number3
StatePublished - 2000
Externally publishedYes

Fingerprint

Body Dysmorphic Disorders
Research
Neuroimaging
Therapeutics
Depression
Drug Therapy
7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Body dysmorphic disorder. / Allen, A.; Hollander, Eric.

In: Psychiatric Clinics of North America, Vol. 23, No. 3, 2000, p. 617-628.

Research output: Contribution to journalArticle

Allen, A. ; Hollander, Eric. / Body dysmorphic disorder. In: Psychiatric Clinics of North America. 2000 ; Vol. 23, No. 3. pp. 617-628.
@article{a701b825e7fe40ceb84f187f8c4120ef,
title = "Body dysmorphic disorder",
abstract = "The understanding of BDD and its treatment has expanded significantly in the past decade as controlled research has followed the leads from case reports and clinical experience. BDD is recognized as a severe, disabling disorder that is more common that had been assumed. Although BDD is still difficult to treat, success has been demonstrated for SRIs and CBT. Much remains to be discovered. To date, little is known about the causes and pathophysiology of BDD. Research that would illuminate these also would increase understanding of its relationship to other disorders, such as OCD, depression, and social phobia, and open up possibilities for prevention and new approaches to treatment. Investigations in brain imaging and genetics are underway. Research in pharmacotherapy and CBT, individually and combined, is needed to refine, extend, and optimize treatment.",
author = "A. Allen and Eric Hollander",
year = "2000",
language = "English (US)",
volume = "23",
pages = "617--628",
journal = "Psychiatric Clinics of North America",
issn = "0193-953X",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Body dysmorphic disorder

AU - Allen, A.

AU - Hollander, Eric

PY - 2000

Y1 - 2000

N2 - The understanding of BDD and its treatment has expanded significantly in the past decade as controlled research has followed the leads from case reports and clinical experience. BDD is recognized as a severe, disabling disorder that is more common that had been assumed. Although BDD is still difficult to treat, success has been demonstrated for SRIs and CBT. Much remains to be discovered. To date, little is known about the causes and pathophysiology of BDD. Research that would illuminate these also would increase understanding of its relationship to other disorders, such as OCD, depression, and social phobia, and open up possibilities for prevention and new approaches to treatment. Investigations in brain imaging and genetics are underway. Research in pharmacotherapy and CBT, individually and combined, is needed to refine, extend, and optimize treatment.

AB - The understanding of BDD and its treatment has expanded significantly in the past decade as controlled research has followed the leads from case reports and clinical experience. BDD is recognized as a severe, disabling disorder that is more common that had been assumed. Although BDD is still difficult to treat, success has been demonstrated for SRIs and CBT. Much remains to be discovered. To date, little is known about the causes and pathophysiology of BDD. Research that would illuminate these also would increase understanding of its relationship to other disorders, such as OCD, depression, and social phobia, and open up possibilities for prevention and new approaches to treatment. Investigations in brain imaging and genetics are underway. Research in pharmacotherapy and CBT, individually and combined, is needed to refine, extend, and optimize treatment.

UR - http://www.scopus.com/inward/record.url?scp=0033857590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033857590&partnerID=8YFLogxK

M3 - Article

C2 - 10986731

AN - SCOPUS:0033857590

VL - 23

SP - 617

EP - 628

JO - Psychiatric Clinics of North America

JF - Psychiatric Clinics of North America

SN - 0193-953X

IS - 3

ER -